Skip to content

Development of interactive software for a digital dermatoscope

Development of interactive software for a digital dermatoscope - Magnos2

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036385
Enrollment
410
Registered
2025-03-12
Start date
2025-03-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43-C44

Interventions

Group 1: Patients with suspected skin tumors or precursors are examined once with a digital dermatoscope before the lesion is removed or treated. Dermatoscopic images are evaluated with a confirmed di

Sponsors

Magnosco GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - who are suspected of having a skin tumor or a precursor and a confirmed diagnosis is available after further treatment. - who have been informed about the aims of the study and the nature of the examinations. - who have given their written informed consent to participate.

Exclusion criteria

Exclusion criteria: - children - Persons who have not given their informed consent in writing - Persons who cannot make decisions on their own responsibility

Design outcomes

Primary

MeasureTime frame
The aim of the study is the non-hypothesis-driven, precise determination of the diagnostic accuracy of the AI.

Secondary

MeasureTime frame
Automatic recording of parameters such as lesion size, homogeneity and color distribution can contribute to the diagnosis. This is to be developed with regard to the analysis of image data, including dark skin types.

Countries

Germany

Contacts

Public ContactMartina Meinke

Charité – Universitätsmedizin Berlin

martina.meinke@charite.de+4930450518235

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026